All

Fujifilm Launches Balloon-less Ultrasound Bronchoscope for Pulmonary Care

The new EB-710US device aims to reduce infection risks and streamline procedure preparation by eliminating the use of disposable balloons.

All

What Not to Miss at the 2026 AAMI eXchange

From a new dental pavilion to a repair-a-thon for global health, here are five can't-miss stops heading to Denver this May.

All

Avicenna.AI Launches Platform to Bring Imaging AI Into Existing Workflows

The new platform integrates imaging AI tools into existing systems and supports GDPR- and HIPAA-compliant data handling.

All

Fujifilm Launches Balloon-less Ultrasound Bronchoscope for Pulmonary Care

The new EB-710US device aims to reduce infection risks and streamline procedure preparation by eliminating the use of disposable balloons.

FDA Clears CT-Based Ventilation-Perfusion Software

Sep 4, 2025

The solution converts standard non-contrast chest CTs into quantitative lung function maps and has also received CMS reimbursement confirmation.

Olympus Launches New Imaging Platform for ENT, Urology

Sep 2, 2025

The system integrates multiple light sources and is designed for compatibility with a range of endoscopes in office and outpatient settings.

Studycast Acquires UltraLinQ, Merging Cloud-Based Imaging Platforms

Aug 27, 2025

The acquisition brings UltraLinQ’s cloud PACS and cardiac monitoring solutions under Core Sound Imaging’s Studycast platform as part of a strategic growth initiative.

Rhapsody Releases Image Director to Modernize Imaging Workflows

Aug 18, 2025

The new image orchestration solution is designed to simplify DICOM routing, reduce infrastructure complexity, and prepare healthcare systems for multimodal AI.

White Paper Offers Best Practices for Medical Imaging Cybersecurity

Aug 7, 2025

The document outlines common imaging device outage scenarios and manufacturers’ recommended steps to mitigate the impact and keep systems functioning.

MDUFA VI Process Officially Begins With FDA Public Meeting

Aug 4, 2025

AdvaMed leaders call for a continued focus on timely patient access and regulatory predictability as the FDA opens discussions on the next medical device user fee agreement.